13366-69-3

Basic information

• Product Name: Phenol, 2-amino-3-methyl-6-(1-methylethyl)- (9CI)
• Synonyms: Phenol, 2-amino-3-methyl-6-(1-methylethyl)- (9CI)
• CAS NO: 13366-69-3
• Molecular Formula: C₁₀H₁₅NO
• Molecular Weight: 165.2322
• Product Categories: ISOPROPYL
• Mol File: 13366-69-3.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Phenol, 2-amino-3-methyl-6-(1-methylethyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Phenol, 2-amino-3-methyl-6-(1-methylethyl)- (9CI)(13366-69-3)
• EPA Substance Registry System: Phenol, 2-amino-3-methyl-6-(1-methylethyl)- (9CI)(13366-69-3)

Safety Data

• Hazardous Substances Data: 13366-69-3(Hazardous Substances Data)

Upstream product

• 217095-74-4 4-chloro-6-isopropyl-3-methyl-2-nitrophenol 
• 86031-16-5 6-Nitrothymol 

Relevant articles and documents

Cyclic diamine compounds and medicine containing the same

The present invention offers novel cyclic diamine compounds and a pharmaceutical composition containing the same. The present invention relates to a compound represented by the formula (I) or salt(s) or solvate(s) thereof. (In the formula, is an optionally substituted divalent residue of benzene, pyridine, cyclohexane or naphthalene or is a vinylene group where Ar is an optionally substituted aryl group;X is —NH—, oxygen atom or sulfur atom;Y is —NR1—, oxygen atom, sulfur atom, sulfoxide or sulfone;Z is a single bond or —NR2—;R1 is hydrogen atom, optionally substituted lower alkyl group, optionally substituted aryl group or optionally substituted silyl lower alkyl group;R2 is hydrogen atom, optionally substituted lower alkyl group, optionally substituted aryl group or optionally substituted silyl lower alkyl group;l is an integer of from 0 to 15;m is an integer of 2 or 3; andn is an integer of from 0 to 3). The compound of the present invention is useful as a pharmaceutical composition, particuarly as an inhibitor of acyl coenzyme A cholesterol acyltransferase (ACAT).

Alkyl-substituted benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same

A novel rifamycin derivative having the formula (I): STR1 wherein X1 is an alkyl group with 1 to 6 carbon atoms or a cycloalkyl group with 3 to 8 carbon atoms; X2 is a hydrogen atom or an alkyl group with 1 to 4 carbon atoms; R1 is hydrogen atom or acetyl group; A is a group represented by the formula: STR2 wherein R2 is an alkyl group with 1 to 4 carbon atoms or an alkoxyalkyl group with 2 to 6 carbon atoms and R3 is an alkyl group with 1 to 6 carbon atoms or an alkoxyalkyl group with 2 to 6 carbon atoms, or a group represented by the formula STR3 wherein STR4 is a 3 to 9 membered cyclic amino group with 2 to 8 carbon atoms, R4 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, or salts thereof, a process for preparing the same and antibacterial agents containing the same as an effective ingredient. The rifamycin derivative of the present invention having the formula (I) shows a strong antibacterial activity against the Gram-positive bacteria and the acid-fast bacteria.